Fundraising Fox
🦊/People
Sign in

Steve Tregay

Investor

Managing Partner at Mission Biocapital · Board director at Alessa Therapeutics

Cambridge, Massachusetts

Writes $500K checks · typically $1.5M

Find your path to Steve

492 people in our graph share verified history with Steve — schools, employers, funds. One of them is your warm intro.

Adam ValkinunlockedSteve: together at Harvard University (1993–1996)
×9Steve: together at Harvard University
×2Steve: together at Mission Biocapital

About

Steve Tregay, a big‑pharma executive, venture capitalist and biotech founder‑CEO, serves as founding CEO and guides companies from research to clinical development while chairing LabCentral, building shared labs in Cambridge.

Contact· self-published, not guessed

Invests in

AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials

Board director at Alessa Therapeutics

Intro paths

→

In turn, Steve can intro founders to Alessa Therapeutics's investors below.

Alessa Therapeutics's investors · 4

Cure VenturesBoston · since 2025Mission Bay CapitalSan FranciscoMission BiocapitalSan Francisco · $500K checks · since 2025National Institutes of Health (NIH)since 2021

Co-founders at Alessa Therapeutics

PMPamela Munster
Pamela MunsterFounder, Director & Chief Scientific Advisor

Experience

  1. Mission BioCapitalManaging General Partnercurrent2019 — presentCambridge, MA
  2. FORMA TherapeuticsFounder, President and CEO2008 — 2019
  3. Compass Therapeutics LLCFounder and Chairman of the Board of Directors2015 — 2019Cambridge MA
  4. Novartis Venture FundManaging Director2006 — 2009
  5. Novartis Institutes for BioMedical Research (NIBR)Executive Director2004 — 2006
  6. Array BioPharmaBusiness Development2001 — 2004

Skills & more

Drug Discovery99Biotechnology99Pharmaceutical Industry99Drug Design21Drug Development94Medicinal Chemistry23Oncology99Lifesciences37Technology Transfer47Clinical Development41CRO14Cancer9
+12 moreChemistryOrganic ChemistryBiopharmaceuticalsCommercializationNeuroscienceGLPBiomarkersVenture CapitalClinical TrialsBiochemistryPharmacologyGMP

From Steve's professional profile.

Deals · 1

Compass TherapeuticsBoard seat

via Mission Biocapital · filed Jul 2018 · $170.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Alessa TherapeuticsCompass Therapeutics LLC

Per SEC Form D filings.

Colleagues at Mission Biocapital

Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital

Frequently asked questions

Who is Steve Tregay?
Steve Tregay, a big‑pharma executive, venture capitalist and biotech founder‑CEO, serves as founding CEO and guides companies from research to clinical development while chairing LabCentral, building shared labs in Cambridge.
Where does Steve Tregay work?
Steve Tregay is Managing Partner at Mission Biocapital and Board director at Alessa Therapeutics.
What does Steve Tregay invest in?
Steve Tregay invests in AgTech, Biotech, FoodTech, Healthtech, Medical Devices, New Materials.
What check size does Steve Tregay write?
Steve Tregay typically writes checks of $500K.
What boards does Steve Tregay sit on?
Steve Tregay holds tracked board seats at Alessa Therapeutics, Compass Therapeutics LLC.
Where did Steve Tregay go to school?
Steve Tregay studied at Harvard University (Ph.D., MS); Davidson College (BS, Chemistry).

Same school

Shared employers